Clinical Trial Update: fMRI Study Examining Effects of D-cycloserine in Specific Phobia [Phase 2]

View source ↗

Summary

Phase 2 fMRI study evaluating the effects of D-cycloserine in individuals with specific phobia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Specific Phobia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Phobias | Phase 2 | Status: COMPLETED | Results posted: 2017-06-05